ROSELLINI MICHAEL 4
4 · NEXEON MEDSYSTEMS INC · Filed Oct 6, 2017
Insider Transaction Report
Form 4
ROSELLINI MICHAEL
Other
Transactions
- Conversion
Common Stock
2017-06-23+104,890→ 821,890 total - Conversion
Common Stock
2017-06-23+102,000→ 702,000 total(indirect: By IRA) - Other
Warrants
2017-06-23−617,000→ 0 totalFrom: 2016-12-02Exp: 2019-12-02→ Common Stock (104,890 underlying) - Other
Warrants
2017-06-23−600,000→ 0 total(indirect: By IRA)From: 2016-12-02Exp: 2019-12-02→ Common Stock (102,000 underlying)
Footnotes (5)
- [F1]Shares held by the Michael Rosellini ROTH IRA. Dr. Rosellini has the sole power to vote and dispose of the shares held by the Michael Rosellini ROTH IRA.
- [F2]Warrants held by the Michael Rosellini ROTH IRA. Dr. Rosellini has the sole power to vote and dispose of the warrants/shares held by the Michael Rosellini ROTH IRA.
- [F3]On March 21, 2017, the Company offered to current warrant holders who participated in the 2016 Private Placement which closed on December 2, 2016, the opportunity to convert their warrants into common stock of the Company on the following terms ("Warrant Conversion Offer"). The offer terms included the exercise of seventeen (17) warrants for seventeen (17) shares of the Company's common stock at an exercise price of $0.01 per share for every one hundred (100) warrants owned. The remaining eighty-three (83) warrants per hundred warrants owned would be cancelled. The offer was on an all-or-nothing basis to convert all warrants held by each warrant holder.
- [F4]Pursuant to the terms of the Warrant Conversion Offer, on June 23, 2017, of the 617,000 warrants held by Dr. Rosellini individually, 104,890 warrants were converted into 104,890 shares of common stock, and 512,110 warrants were cancelled.
- [F5]Pursuant to the terms of the Warrant Conversion Offer, on June 23, 2017, of the 600,000 warrants held by the Michael Rosellini ROTH IRA, 102,000 warrants were converted into 102,000 shares of common stock and 498,000 warrants were cancelled.